CEACAM16: A Potential Drug Target and Biomarker for Tectorial Membrane Component

Target Name: CEACAM16

NCBI ID: G388551

CEACAM16

CEACAM16: A Potential Drug Target and Biomarker for Tectorial Membrane Component

Introduction

Membranes play a crucial role in various physiological processes in the body, including the regulation of cell-cell interactions and the maintenance of tissue structure. The tectorial membrane component (TMC) of the cell adhesion molecule 16 (CEA) is a key protein that contributes to the maintenance of tight cell-cell adhesion and tissue structure. CEA is a transmembrane protein that plays a central role in cell-cell adhesion, as well as influencing tissue regeneration and plasticity. The TMC is a key component of CEA, and its function is essential for the overall stability of CEA-mediated cell-cell adhesion.

Recent studies have identified CEACAM16 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will provide an overview of CEACAM16, its function in cell-cell adhesion, and its potential as a drug target and biomarker.

Function of CEACAM16

CEACAM16 is a 21-kDa protein that is expressed in various tissues, including brain, heart, skeletal muscles, and organs. It is a key component of the CEA family of proteins, which are involved in cell-cell adhesion and the regulation of tissue structure. CEACAM16 functions as a transmembrane protein that is involved in the regulation of CEA-mediated cell-cell adhesion.

CEACAM16 plays a crucial role in the regulation of cell-cell adhesion by interacting with various cell surface molecules, including cadherins, integrins, and tight junction proteins. It helps to regulate the distribution of these molecules along the cell membrane and ensures that they remain in their correct positions, which is essential for the formation of tight junctions and the maintenance of tissue structure.

In addition to its role in cell-cell adhesion, CEACAM16 has also been shown to play a key role in the regulation of cell survival and plasticity. It has been shown to be involved in various cellular processes, including cell apoptosis, cell cycle progression, and plasticity, and has been identified as a potential drug target for various diseases.

Potential Drug Target

The potential drug target for CEACAM16 is based on its role in cell-cell adhesion and its involvement in various cellular processes. Drugs that target CEACAM16 have the potential to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One approach to targeting CEACAM16 is to use small molecules that can inhibit its activity. These molecules can be designed to interact with specific CEACAM16 domains, such as the N-terminus or the C-terminus, and can either inhibit or enhance its activity.

Another approach to targeting CEACAM16 is to use antibodies that can specifically recognize and label it in the cells. These antibodies can be used to study its distribution and function in different tissues and can also be used to treat diseases by blocking its activity.

Biomarker

CEACAM16 can also be used as a biomarker for various diseases. Its expression is often reduced in diseases, such as cancer, neurodegenerative diseases, and autoimmune disorders, and can be used as a diagnostic or monitoring tool.

In addition to its use as a biomarker, CEACAM16 has also been shown to be involved in the regulation of various biological processes, including cell apoptosis, cell cycle progression, and plasticity. This suggests that it may be a useful biomarker for studying the effects of drugs on these processes and for identifying potential drug targets.

Conclusion

CEACAM16 is a protein that plays a crucial role in the regulation of cell-cell adhesion and the maintenance of tissue structure. Its function is essential for the overall stability of CEA-mediated cell-cell adhesion and for the regulation of cell survival and plasticity.

Recent studies have identified CEACAM16 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The potential drug targets for CEACAM16 are based on its role in cell-cell adhesion and its involvement in various cellular processes. CEACAM16 can also be used as a biomarker for studying the effects of drugs on these processes.

Future studies are needed to further explore the function of CEACAM16 and its potential as a drug target and biomarker. The development of new treatments for diseases that are characterized by the dysfunction of CEACAM16 will have a significant impact on our understanding of these diseases and may lead to new treatments for the future.

Protein Name: CEA Cell Adhesion Molecule 16, Tectorial Membrane Component

Functions: Required for proper hearing, plays a role in maintaining the integrity of the tectorial membrane

The "CEACAM16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CEACAM16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets